Psoriasis is associated with an increased risk of atherosclerosis. Endothelial dysfunction is the critical early step in the process of atherogenesis, and it is commonly investigated by measuring arterial stiffness. We aimed to investigate the relationship between arterial stiffness and high-sensitivity C-reactive protein (hsCRP) in patients with psoriasis. A total of 32 patients with psoriasis and 35 patients with other skin diseases were included in the study. The hsCRP levels and arterial stiffness measurements were compared. Arterial stiffness was significantly different between the 2 groups (P = .01). Arterial stiffness was not associated with the duration of the disease or the disease activity (P = .34 and .64, respectively). In patients with psoriasis, arterial stiffness correlated positively with age, sex, body mass index, diastolic blood pressure, and hsCRP level (P < .05). These findings provide further evidence of a link between inflammation, premature atherosclerosis, and psoriasis.
GisondiPFerrazziAGirolomoniG. Metabolic comorbidities and psoriasis. Acta Dermatovenerol Croat. 2010;18(4):297–304.
2.
NeimannALShinDBWangXMargolisDJTroxelABGelfandJM. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol. 2006;55(5):829–835.
3.
YiuKHYeungCKChanHT. Increased arterial stiffness in patients with psoriasis is associated with active systemic inflammation. Br J Dermatol. 2011;164(3):514–520.
4.
GelfandJMNeimannALShinDBWangXMargolisDJTroxelAB. Risk of myocardial infarction in patients with psoriasis. JAMA. 2006;296(14):1735–1741.
5.
GelfandJMMehtaNNLanganSM. Psoriasis and cardiovascular risk: strength in numbers, part II. J Invest Dermatol. 2011;131(5):1007–1010.
6.
TziomalosKTziomalosKSivanadarajahNMikhailidisDPBoumpasDTSeifalianAM. Increased risk of vascular events in systemic lupus erythematosus: is arterial stiffness a predictor of vascular risk?Clin Exp Rheumatol. 2008;26(6):1134–1145.
7.
AhlehoffOGislasonGHCharlotM. Psoriasis is associated with clinically significant cardiovascular risk: a Danish nationwide cohort study. J Intern Med. 2011;270(2):147–157.
8.
GisondiPFantinFDel GiglioM. Chronic plaque psoriasis is associated with increased arterial stiffness. Dermatology. 2009;218(2):110–113.
9.
DoonanRJHausvaterAScallanC. The effect of smoking on arterial stiffness. Hypertens Res. 2010;33(5):398–410.
FredrikssonTPetterssonU. Severe psoriasis—oral therapy with a new retinoid. Dermatologica. 1978;157(4):238–244.
12.
McDonaldCJCalabresiP. Complication of psoriasis. JAMA. 1973;224(5):629.
13.
McDonaldCJCalabresiP. Occlusive vascular disease in psoriatic patients. N Engl J Med. 1973;288(17):912.
14.
MaCHarskampCTArmstrongEJArmstrongAW. The association between psoriasis and dyslipidaemia: a systematic review. Br J Dermatol. 2013;168(3):486–495.
15.
Maradit-KremersHDierkhisingRACrowsonCSIcenMErnsteFCMcEvoyMT. Risk and predictors of cardiovascular disease in psoriasis: a population-based study. Int J Dermatol. 2013;52(1):32–40.
16.
BalciDDBalciAKarazincirS. Increased carotid artery intima-media thickness and impaired endothelial function in psoriasis. J Eur Acad Dermatol Venereol. 2009;23(1):1–6.
17.
CostaLCasoFD'EliaL. Psoriatic arthritis is associated with increased arterial stiffness in the absence of known cardiovascular risk factors: a case control study. Clin Rheumatol. 2012;31(4):711–715.
18.
DemirkolSBaltaSUnluM. Neutrophils/lymphocytes ratio in patients with cardiac syndrome X and its association with carotid intima-media thickness [published online November 26, 2012]. Clin Appl Thromb Hemost. 2012.
19.
BaltaSCakarMDemirkolS. Arterial stiffness itself without other inflammatory markers may not provide information to clinicians [published online February 1, 2013]. J Clin Hypertens (Greenwich). 2013.
20.
BaltaSDemirkolSCelikT. Association between coronary artery ectasia and neutrophil–lymphocyte ratio [published online March 7, 2013]. Angiology. 2013. doi:10.1177/0003319713480424
21.
YildizM. Arterial distensibility in chronic inflammatory rheumatic disorders. Open Cardiovasc Med J. 2010;4:83–88.
22.
BacaksizAAkif VatankuluMSonmezO. Non-dipping nocturnal blood pressure in psoriasis vulgaris. Wien Klin Wochenschr. 2012;124(23-24):822–829.
23.
ArmstrongAWHarskampCTArmstrongEJ. Psoriasis and metabolic syndrome: a systematic review and meta-analysis of observational studies. J Am Acad Dermatol. 2013;68(4):654–662.
24.
XiaoJChenLHTuYTDengXHTaoJ. Prevalence of myocardial infarction in patients with psoriasis in central China. J Eur Acad Dermatol Venereol. 2009;23(11):1311–1315.
25.
FedermanDGShellingMProdanovichSGundersonCGKirsnerRS. Psoriasis: an opportunity to identify cardiovascular risk. Br J Dermatol. 2009;160(1):1–7.
26.
LeeJHChoKIKimSM. Carotid arterial stiffness in patients with rheumatoid arthritis assessed by speckle tracking strain imaging: its association with carotid atherosclerosis. Clin Exp Rheumatol. 2012;30(5):720–728.
27.
ProdanovichSMaFTaylorJRPezonCFasihiTKirsnerRS. Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis. J Am Acad Dermatol. 2005;52(2):262–267.
28.
GraceAABarradasMAMikhailidisDP. Cyclosporine a enhances platelet aggregation. Kidney Int. 1987;32(6):889–895.
29.
BoselloSSantoliquidoAZoliA. TNF-alpha blockade induces a reversible but transient effect on endothelial dysfunction in patients with longstanding severe rheumatoid arthritis. Clin Rheumatol. 2008;27(7):833–839.
30.
PapadakisJASidiropoulosPIKarvounarisSA. High prevalence of metabolic syndrome and cardiovascular risk factors in men with ankylosing spondylitis on anti-TNF alpha treatment: correlation with disease activity. Clin Exp Rheumatol. 2009;27(2):292–298.
